We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.8B
AUM Growth
+$1.27B
(+3.7%)
Cap. Flow
-$817M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
13.63%
Holding
2,806
New
288
Increased
941
Reduced
1,236
Closed
310
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$563M |
| 2 |
McDonald's
MCD
|
+$357M |
| 3 |
Tesla
TSLA
|
+$268M |
| 4 |
Advanced Micro Devices
AMD
|
+$253M |
| 5 |
PayPal
PYPL
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$485M |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Merck
MRK
|
+$217M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$200M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.67% |
| 2 | Healthcare | 17.85% |
| 3 | Industrials | 11.58% |
| 4 | Financials | 11.17% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Nature's Sunshine
NATR
$365M
| $339K | ﹤0.01% |
40,800
-8,800
| -18% | -$74.5K |
|
2027
Stoke Therapeutics
STOK
$1.83B
| $338K | ﹤0.01% |
36,600
+11,000
| +43% | +$114K |
|
2028
TTM Technologies
TTMI
$11.3B
| $336K | ﹤0.01% |
22,300
+300
| +1% | +$4.45K |
|
2029
Fabrinet
FN
$16.1B
| $333K | ﹤0.01% |
2,600
-21,500
| -89% | -$2.57M |
|
|
TBI
2030
Trueblue
TBI
$235M
| $333K | ﹤0.01% |
+17,000
| New | +$345K |
|
2031
Simulations Plus
SLP
$371M
| $333K | ﹤0.01% |
9,100
+3,300
| +57% | +$139K |
|
2032
GCM Grosvenor
GCMG
$745M
| $333K | ﹤0.01% |
43,700
-3,100
| -7% | -$25.3K |
|
2033
Utah Medical Products
UTMD
$226M
| $332K | ﹤0.01% |
3,300
| – | – |
|
2034
FirstEnergy
FE
$28.7B
| $331K | ﹤0.01% |
7,900
-401,300
| -98% | -$15.7M |
|
2035
Full House Resorts
FLL
$83.8M
| $331K | ﹤0.01% |
44,000
-21,100
| -32% | -$146K |
|
2036
Babcock & Wilcox
BW
$1.31B
| $330K | ﹤0.01% |
57,227
-44,000
| -43% | -$240K |
|
2037
USCB Financial Holdings
USCB
$414M
| $329K | ﹤0.01% |
+27,000
| New | +$358K |
|
2038
Oric Pharmaceuticals
ORIC
$1.23B
| $328K | ﹤0.01% |
55,700
-112,586
| -67% | -$380K |
|
2039
Agnico Eagle Mines
AEM
$71.9B
| $328K | ﹤0.01% |
6,309
-43,691
| -87% | -$2.06M |
|
2040
Oportun Financial
OPRT
$264M
| $323K | ﹤0.01% |
58,700
-18,000
| -23% | -$94.1K |
|
|
YMAB
2041
DELISTED
Y-mAbs Therapeutics
YMAB
| $323K | ﹤0.01% |
+66,100
| New | +$480K |
|
|
SLGC
2042
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $322K | ﹤0.01% |
128,300
+41,600
| +48% | +$116K |
|
2043
Inseego
INSG
$111M
| $322K | ﹤0.01% |
38,220
-13,060
| -25% | -$196K |
|
|
OGI
2044
Organigram Holdings
OGI
$134M
| $322K | ﹤0.01% |
100,518
-15,375
| -13% | -$57.8K |
|
2045
Marcus Corp
MCS
$766M
| $321K | ﹤0.01% |
22,300
-42,738
| -66% | -$647K |
|
2046
Home Bancorp
HBCP
$563M
| $320K | ﹤0.01% |
8,000
-3,800
| -32% | -$158K |
|
2047
Mohawk Industries
MHK
$7.14B
| $319K | ﹤0.01% |
+3,124
| New | +$306K |
|
2048
Townsquare Media
TSQ
$104M
| $319K | ﹤0.01% |
44,000
-12,700
| -22% | -$95.7K |
|
2049
Comscore
SCOR
$116M
| $319K | ﹤0.01% |
13,745
-6,875
| -33% | -$178K |
|
2050
Warby Parker
WRBY
$3.19B
| $318K | ﹤0.01% |
+23,600
| New | +$361K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, Two Sigma Advisers held 2,806 positions worth $35.8B, up 3.7% from $34.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers's Q4 2022 filing shows 288 new, 941 increased, 1,236 reduced and 310 closed positions. Its largest new stake was Advanced Micro Devices: 3,833,640 shares worth $248M. The largest sale was JPMorgan Chase, an estimated $485M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
- Two Sigma Advisers's largest Q4 2022 buy was Advanced Micro Devices: 3,833,640 shares worth $248M.
- Two Sigma Advisers added most to Amazon in Q4 2022, an estimated $563M increase.
- Two Sigma Advisers's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $485M.
- Two Sigma Advisers fully exited NVIDIA in Q4 2022, selling an estimated $140M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $35.8B portfolio in Q4 2022.
- Two Sigma Advisers opened 288 new positions and closed 310 in Q4 2022.
- Two Sigma Advisers's portfolio value rose 3.7% quarter-over-quarter to $35.8B.
Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.